Cancer Biomarkers

Cancer biomarkers, particular those associated with genetic mutations or epigenetic alterations, often offer a quantitative way to determine when individuals are predisposed to particular types of cancers. A cancer biomarker refers to a substance or process that is indicative of the presence of cancer in the body. A biomarker may be a molecule secreted by a tumor or a specific response of the body to the presence of cancer. Genetic, epigenetic, proteomic, glycomic, and imaging biomarkers can be used for cancer diagnosis, prognosis, and epidemiology.

  • Biomarkers in cancer research
  • Biomarkers in medicine
  • Risk assessment, diagnosis
  • Prognosis and treatment predictions
  • Molecular cancer biomarkers

 

    Related Conference of Cancer Biomarkers

    April 22-23, 2019

    16th Annual Conference on Laboratory Medicine & Pathology

    Kuala Lumpur, Malaysia
    May 9-10, 2019

    17th European Pathology Congress

    | Amsterdam, Netherlands
    June 28-29, 2019

    Breast Pathology 2019

    Oslo, Norway
    July 31 - August 1, 2019

    International Conference on Surgical Pathology

    Amsterdam,Netherlands
    July 31- August 01, 2019

    International Conference on Molecular Pathology

    Amsterdam | Netherlands
    August 21-22, 2019

    17th Asia Pacific Pathology Congress

    Mercure Singapore on Stevens, Singapore
    November 08 09, 2019

    18th Global Congress on Pathology

    San Francisco | California | United States
    November 25-26, 2019

    2nd European Pathology and Infectious Disease Conference

    Helsinki, Finland

    Cancer Biomarkers Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in